Cliramitug
Cliramitug is a monoclonal antibody targeting human transthyretin (TTR) . Cliramitug binds to TTR to inhibit its amyloid-forming process, exerting activity against amyloid protein formation. Cliramitug is promising for research of diseases related to transthyretin amyloidosis, such as certain neurological and cardiovascular diseases[1].
Product Specifications
CAS Number
2965214-50-8
Product Name Alternative
NI-006; ALXN2220
UNSPSC
12352203
Target
Transthyretin (TTR)
Related Pathways
Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease; Cardiovascular Disease
Purity
97.0
Smiles
[Cliramitug]
Molecular Weight
(144.542 kDa)
References & Citations
[1]World Health Organization. WHO Drug Information: Volume 38[M]. World Health Organization, 2024.
Shipping Conditions
Dry Ice
Storage Conditions
-80°C
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6356416-01 0.2 mL
TMEM17, NT (TMEM17, Transmembrane protein 17) (AP)
Sign In for Pricing
View Details MBS6356416-02 5x 0.2 mL
TMEM17, NT (TMEM17, Transmembrane protein 17) (AP)
Sign In for Pricing
View Details 
MBS1436244 Inquire
Recombinant Mouse 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1 (Plce1) , partial
Sign In for Pricing
View Details 